EVALUATION OF MRNA COVID-19 VACCINE REACTOGENICITY AND SAFETY IN MYASTHENIA GRAVIS PATIENTS.

被引：0
|
作者：
Gamez, Josep [1 ]
Gamez, Alejandro [2 ]
Carmona, Francesc [3 ]
机构：
[1] Autonomous Univ Barcelona, European Reference Network Rare Neuromuscular Dis, Neurol Dept, GMA Clin, Barcelona, Spain
[2] Hosp San Rafael, Neurophtalmol Dept, Barcelona, Spain
[3] Univ Barcelona, Dept Genet Microbiol & Stat, Barcelona, Spain
来源：
MUSCLE & NERVE | 2022年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [31] Case Series of Myasthenia Gravis patients with COVID-19 infection
    Suri, Ritika
    Chandok, Arun
    Sripathi, Naganand
    Grover, Kavita
    NEUROLOGY, 2021, 96 (15)
  • [32] Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis
    Frauke Stascheit
    Ulrike Grittner
    Sarah Hoffmann
    Philipp Mergenthaler
    Michael Schroeter
    Tobias Ruck
    Mark Pawlitzki
    Franz Blaes
    Julia Kaiser
    Ulrike Schara
    Adela Della-Marina
    Andrea Thieme
    Tim Hagenacker
    Christian Jacobi
    Benjamin Berger
    Peter P. Urban
    Karl Christian Knop
    Berthold Schalke
    De-Hyung Lee
    Petra Kalischewski
    Heinz Wiendl
    Andreas Meisel
    Journal of Neurology, 2023, 270 : 1 - 12
  • [33] ASSOCIATION BETWEEN MYASTHENIA GRAVIS AND OUTCOMES IN COVID-19 PATIENTS
    Thepmankorn, Parisorn
    Patlolla, Rishita
    Heshmati, Keyvan
    Malerba, Stefano
    Arismendi, Gabriel
    Souayah, Sami
    Adam, Nabil
    Souayah, Nizar
    MUSCLE & NERVE, 2021, 64 : S12 - S12
  • [34] Clinical course and outcome of Covid-19 in patients with myasthenia gravis
    Aktoz, Gonulden
    Boz, Cavit
    Zengin, Serap
    Okumus, Aleyna Caglar
    Horozoglu, Hilal
    Kara, Fatma
    Oral, Ebru
    Ozmenoglu, Mehmet
    NEUROLOGICAL RESEARCH, 2023, 45 (06) : 583 - 589
  • [35] CLINICAL COURSE OF COVID-19 IN PATIENTS WITH PREEXISTING MYASTHENIA GRAVIS
    Daif, Ahmad
    Gapchup, Tejal
    Paul, Pritikanta
    MUSCLE & NERVE, 2022, 66 : S97 - S97
  • [36] Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis
    Stascheit, Frauke
    Grittner, Ulrike
    Hoffmann, Sarah
    Mergenthaler, Philipp
    Schroeter, Michael
    Ruck, Tobias
    Pawlitzki, Mark
    Blaes, Franz
    Kaiser, Julia
    Schara, Ulrike
    Della-Marina, Adela
    Thieme, Andrea
    Hagenacker, Tim
    Jacobi, Christian
    Berger, Benjamin
    Urban, Peter P.
    Knop, Karl Christian
    Schalke, Berthold
    Lee, De-Hyung
    Kalischewski, Petra
    Wiendl, Heinz
    Meisel, Andreas
    JOURNAL OF NEUROLOGY, 2023, 270 (01) : 1 - 12
  • [37] TREATMENT OF MYASTHENIA GRAVIS PATIENTS WITH COVID-19: REVIEW OF THE LITERATURE
    Zupanic, Sven
    Lazibat, Ines
    Majdak, Maja Rubinic
    Jelicic, Mia
    ACTA CLINICA CROATICA, 2021, 60 (03) : 496 - 509
  • [38] COVID-19 in patients with myasthenia gravis: Epidemiology and disease course
    Businaro, Pietro
    Vaghi, Gloria
    Marchioni, Enrico
    Diamanti, Luca
    Arceri, Sebastiano
    Bini, Paola
    Colombo, Elena
    Cosentino, Giuseppe
    Alfonsi, Enrico
    Costa, Alfredo
    Ravaglia, Sabrina
    Mallucci, Giulia
    Ballante, Elena
    Franciotta, Diego
    Gastaldi, Matteo
    MUSCLE & NERVE, 2021, 64 (02) : 206 - 211
  • [39] Impact of the COVID-19 pandemic on Myasthenia Gravis patients: A survey of the Myasthenia Gravis Foundation of America Registry
    De Leon-Benedetti, Andres
    Aban, Inmaculada
    McPherson, Tarrant
    Granit, Volkan
    Benatar, Michael
    Cutter, Gary
    Lee, Ikjae
    NEUROLOGY, 2021, 96 (15)
  • [40] Early safety and tolerability profile of the BNT162b2 COVID-19 vaccine in myasthenia gravis
    Lotan, Itay
    Hellmann, Mark A.
    Friedman, Yitzhak
    Stiebel-Kalish, Hadas
    Steiner, Israel
    Wilf-Yarkoni, Adi
    NEUROMUSCULAR DISORDERS, 2022, 32 (03) : 230 - 235
12345